Regeneron begins COVID-19 antibody cocktail late-stage trial
BENGALURU : Regeneron Pharmaceuticals Inc said on Monday it began late-stage clinical trials to assess the effectiveness of its antibody cocktail in preventing and treating COVID-19, sending its shares up…